Warfarin-Induced Artery Calcification Is Accelerated by Growth and Vitamin D

Abstract

Abstract-The present studies demonstrate that growth and vitamin D treatment enhance the extent of artery calcification in rats given sufficient doses of Warfarin to inhibit ␥-carboxylation of matrix Gla protein, a calcification inhibitor known to be expressed by smooth muscle cells and macrophages in the artery wall. The first series of experiments examined the influence of age and growth status on artery calcification in Warfarin-treated rats. Treatment for 2 weeks with Warfarin caused massive focal calcification of the artery media in 20-day-old rats and less extensive focal calcification in 42-day-old rats. In contrast, no artery calcification could be detected in 10-month-old adult rats even after 4 weeks of Warfarin treatment. To directly examine the importance of growth to Warfarin-induced artery calcification in animals of the same age, 20-day-old rats were fed for 2 weeks either an ad libitum diet or a 6-g/d restricted diet that maintains weight but prevents growth. Concurrent treatment of both dietary groups with Warfarin produced massive focal calcification of the artery media in the ad libitum-fed rats but no detectable artery calcification in the restricted-diet, growth-inhibited group. Although the explanation for the association between artery calcification and growth status cannot be determined from the present study, there was a relationship between higher serum phosphate and susceptibility to artery calcification, with 30% higher levels of serum phosphate in young, ad libitum-fed rats compared with either of the groups that was resistant to Warfarin-induced artery calcification, ie, the 10-month-old rats and the restricted-diet, growth-inhibited young rats. This observation suggests that increased susceptibility to Warfarin-induced artery calcification could be related to higher serum phosphate levels. The second set of experiments examined the possible synergy between vitamin D and Warfarin in artery calcification. High doses of vitamin D are known to cause calcification of the artery media in as little as 3 to 4 days. High doses of the vitamin K antagonist Warfarin are also known to cause calcification of the artery media, but at treatment times of 2 weeks or longer yet not at 1 week. In the current study, we investigated the synergy between these 2 treatments and found that concurrent Warfarin administration dramatically increased the extent of calcification in the media of vitamin D-treated rats at 3 and 4 days. There was a close parallel between the effect of vitamin D dose on artery calcification and the effect of vitamin D dose on the elevation of serum calcium, which suggests that vitamin D may induce artery calcification through its effect on serum calcium. Because Warfarin treatment had no effect on the elevation in serum calcium produced by vitamin D, the synergy between Warfarin and vitamin D is probably best explained by the hypothesis that Warfarin inhibits the activity of matrix Gla protein as a calcification inhibitor. High levels of matrix Gla protein are found at sites of arte...

Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women

“…Jie et al have reported in a population-based study of postmenopausal women that those with calcified lesions had lower intakes of phylloquinone and impaired vitamin K status than those without lesions (Jie et al, 1995). Vitamin K antagonists, such as warfarin, accelerate calcification of arteries in rat models (Price et al, 2000), whereas there are no comparable data currently available in humans. In the present study, the phylloquinone intake was inversely associated with nonfatal MI, which might be primarily associated with atherosclerosis-related mechanisms.…”

Calcimimetic R-568 Decreases Extraosseous Calcifications in Uremic Rats Treated with Calcitriol

“…Samples of the abdominal aorta, the heart, the right lung, and the remnant kidney were fixed in 10% buffered formalin and subsequently sectioned and stained for mineralization by the von Kossa method. Another portion of the aorta was demineralized in 10% formic acid, and the arterial tissue Ca and P content was measured in the supernatant according to the method described by Price et al (21). Quantification of tissue mineral content was performed as described previously (22).…”

Reducing the Burden of Cardiovascular Calcification in Patients with Chronic Kidney Disease

“…Reprinted from reference (64), with permission. min K for ␥-carboxylation, acquired vitamin K deficiency, as with the use of warfarin, may predispose to vascular calcification (50). It is interesting that calciphylaxis, or calcific uremic arteriolopathy, has been reported with increasing frequency in patients who are treated with warfarin therapy (11).…”